Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Johnson & Johnson (JNJ)  
$207.49 2.70 (1.32%) as of 4:30 Wed 1/7


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 2,630,000,000
Market Cap: 545.70(B)
Last Volume: 7,545,728 Avg Vol: 8,225,128
52 Week Range: $142.06 - $214.17
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     DOW JONES COMPOSITE
    DOW JONES INDUSTRIAL AVERAGE     NYSE COMPOSITE
    S&P 100     S&P 500
    MAJOR MARKET

Rankings:
     
Insider 3 Months    : 8.5
Insider 6 Months    : 8.5
Insider 3/6 Months : 17.4
Guru Rank Number :  29
Guru Rank Value     : 17.2
Guru Occurances    : 6

 

            6 Months   1 Year   2 Year  
 
Company Profile   Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 1,250 1,250 1,250 2,250
Total Buy Value $257,688 $257,688 $257,688 $404,908
Total People Bought 1 1 1 2
Total Buy Transactions 1 1 1 2
Total Shares Sold 21,721 239,973 260,390 334,313
Total Sell Value $4,185,793 $42,880,732 $46,107,532 $57,761,379
Total People Sold 1 4 6 7
Total Sell Transactions 1 5 8 11
End Date 2025-10-09 2025-07-08 2025-01-07 2024-01-08

   
Records found: 642
  Page 1 of 26  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Morikis John G Director   –       •      –    2025-11-26 4 B $206.15 $257,688 D/D 1,250 1,849 2.39 -1%     
   Reed John C EVP, Innovative Medicine, R&D   •       –      –    2025-10-17 4 S $192.71 $4,185,793 D/D (21,721) 10,658 -6%     
   Reed John C EVP, Innovative Medicine, R&D   •       –      –    2025-10-17 4 OE $157.92 $3,430,180 D/D 21,721 32,379     -
   Taubert Jennifer L EVP, WWC. Innovative Medicine   •       –      –    2025-09-04 4 S $177.81 $10,040,883 D/D (56,471) 178,013 -15%     
   Taubert Jennifer L EVP, WWC. Innovative Medicine   •       –      –    2025-09-04 4 OE $101.87 $5,752,701 D/D 56,471 234,484     -
   Forminard Elizabeth Executive VP, General Counsel   •       –      –    2025-08-29 4 D $177.20 $1,695,804 D/D (9,570) 12,853     -
   Forminard Elizabeth Executive VP, General Counsel   •       –      –    2025-08-29 4 OE $115.67 $1,332,634 D/D 11,521 22,423     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2025-08-22 4 S $179.21 $22,548,655 D/D (125,824) 275,967 -15%     
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2025-08-22 4 OE $101.87 $12,817,691 D/D 125,824 401,791     -
   Wolk Joseph J Exec VP, CFO   •       –      –    2025-08-15 4 S $176.91 $2,975,571 D/D (16,820) 14,000 -17%     
   Wolk Joseph J Exec VP, CFO   •       –      –    2025-08-15 4 OE $101.87 $1,713,453 D/D 16,820 30,820     -
   Reed John C EVP, Innovative Medicine, R&D   •       –      –    2025-07-17 4 S $163.55 $3,129,830 D/D (19,137) 10,658 -25%     
   Reed John C EVP, Innovative Medicine, R&D   •       –      –    2025-05-01 4 D $156.31 $1,719,723 D/D (11,002) 29,795     -
   Reed John C EVP, Innovative Medicine, R&D   •       –      –    2025-05-01 4 OE $0.00 $0 D/D 25,255 40,797     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2025-03-18 4 GA $0.00 $0 I/I 130,852 130,852     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2025-03-18 4 GD $0.00 $0 D/D 130,852 275,967     -
   Decker Robert J VP Corporate Controller   •       –      –    2025-02-25 4 S $165.88 $1,160,994 D/D (6,999) 21,001 7%     
   Decker Robert J VP Corporate Controller   •       –      –    2025-02-25 4 OE $101.87 $712,988 D/D 6,999 28,000     -
   Wolk Joseph J Exec VP, CFO   •       –      –    2025-02-18 4 D $156.15 $119,923 D/D (768) 5,345     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2025-02-18 4 D $156.15 $250,152 D/D (1,602) 395,923     -
   Mulholland Kristen EVP, Chief HR Officer   •       –      –    2025-02-18 4 D $156.15 $18,738 D/D (120) 12,975     -
   Swanson James D. EVP, CIO   •       –      –    2025-02-18 4 D $156.15 $22,017 D/D (141) 16,621     -
   Taubert Jennifer L EVP, WWC. Innovative Medicine   •       –      –    2025-02-18 4 D $156.15 $101,654 D/D (651) 170,459     -
   Broadhurst Vanessa EVP, Global Corp Affairs   •       –      –    2025-02-18 4 D $156.15 $24,672 D/D (158) 21,681     -
   Decker Robert J VP Corporate Controller   •       –      –    2025-02-18 4 D $156.15 $14,678 D/D (94) 20,022     -
  642 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 26
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2026 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us